Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Kege Yang"'
Autor:
Hanming Yao, Chengzhi Huang, Jinmao Zou, Weiling Liang, Yue Zhao, Kege Yang, Ziyi Zhong, Shurui Zhou, Jiajia Li, Yaqing Li, Lishu Xu, Kaihong Huang, Guoda Lian
Publikováno v:
Journal of Extracellular Vesicles, Vol 13, Iss 7, Pp n/a-n/a (2024)
Abstract Pancreatic ductal adenocarcinoma (PDAC) is characterised by immune evasion that contribute to poor prognosis. Cancer‐associated fibroblasts (CAFs) play a pivotal role in orchestrating the PDAC tumour microenvironment. We investigated the r
Externí odkaz:
https://doaj.org/article/e1bf69a7b1594b22a954c40d4f801f09
Autor:
Shurui Zhou, Kege Yang, Shaojie Chen, Guoda Lian, Yuzhou Huang, Hanming Yao, Yue Zhao, Kaihong Huang, Dong Yin, Haoming Lin, Yaqing Li
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-19 (2023)
Abstract Background Intrahepatic cholangiocarcinoma (ICC) is a malignant disease characterized by onset occult, rapid progression, high relapse rate, and high mortality. However, data on how the tumor microenvironment (TME) regulates ICC metastasis a
Externí odkaz:
https://doaj.org/article/960007e200cd47a8bceafd6a29f41ada
Autor:
Yue Zhao, Hanming Yao, Kege Yang, Shiji Han, Shangxiang Chen, Yaqing Li, Shaojie Chen, Kaihong Huang, Guoda Lian, Jiajia Li
Publikováno v:
Biomaterials Science. 10:5989-6002
ScAb-ATO-NPs targets PSCs to increase the delivery efficiency of ATO to PSCs. ATO inhibits the activation of PSCs via PI3K/AKT/AP4/galectin-1 pathway and decreases the synthesis of ECM in PDAC, which enhances the chemotherapy in PDAC.
Autor:
Shurui Zhou, Ziyi Zhong, Yanzong Lu, Yunlong Li, Hanming Yao, Yue Zhao, Tairan Guo, Kege Yang, Yaqing Li, Shaojie Chen, Kaihong Huang, Guoda Lian
Publikováno v:
Cancers; Volume 14; Issue 19; Pages: 4722
Pancreatic ductal adenocarcinoma (PDAC) is one of the highest mortalities malignant tumors, which is characterized by difficult diagnosis, rapid progression and high recurrence rate. Nevertheless, PDAC responds poorly to conventional therapies, which
Autor:
Guoda Lian, Linjuan Zeng, Chumei Huang, Yinting Chen, Jiajia Li, Kege Yang, Shaojie Chen, Yaqing Li, Kaihong Huang, Qiubo Zhang
Publikováno v:
Cancer Medicine
Tumor‐associated macrophages (TAMs) are abundant population of inflammatory cells which play an essential role in remodeling tumor microenvironment and tumor progression. Previously, we found the high density of TAMs was correlated with lymph node
Autor:
Kege Yang, Jiajia Li, Linjuan Zeng, Yaqing Li, Chumei Huang, Kaihong Huang, Hong Su, Zuoquan Zhang, Yubo Guo, Jian Li, Yonghui Su, Guoda Lian, Shaojie Chen, Yinting Chen
Publikováno v:
Theranostics
The molecular mechanism of perineural invasion (PNI) is unclear, and insufficient detection during early-stage PNI in vivo hampers its investigation. We aimed to identify a cytokine paracrine loop between pancreatic ductal adenocarcinoma (PDAC) cells
Autor:
Yaqing Li, Lingyun Wang, Linjuan Zeng, Chumei Huang, Zuoquan Zhang, Guoda Lian, Yinting Chen, Jiajia Li, Kaihong Huang, Ying Lin, Kege Yang, Shaojie Chen
Publikováno v:
Cancer Science
Tumor metastasis occurs naturally in pancreatic cancer, and the efficacy of chemotherapy is usually poor. Precision medicine, combining downregulation of target genes with chemotherapy drugs, is expected to improve therapeutic effects. Therefore, we
Autor:
Kege Yang, Linjuan Zeng, Yaqing Li, Kaihong Huang, Chen Yinting, Guoda Lian, Jiajia Li, Shaojie Chen
Publikováno v:
Journal of Biomedical Nanotechnology. 12:1654-1666
BACKGROUND: The concept of precision medicine to treat cancer shows promise and a co-delivery carrier for chemotherapy drugs and target genes is the key tool for both basic research and clinical application. To address this, we developed a cancer-tar
Autor:
Kaihong Huang, Jiajia Li, Chumei Huang, Guoda Lian, Yaqing Li, Linjuan Zeng, Zhong-hua Chu, Shaojie Chen, Yinting Chen, Qiubo Zhang, Kege Yang
Publikováno v:
Tumor Biology. 37:11299-11309
It is critical to understand the pathogenesis of preinvasive stages of pancreatic duct adenocarcinoma (PDAC) for developing novel potential diagnostic and therapeutic targets. The polycomb group family member B-lymphoma Moloney murine leukemia virus
Autor:
Kege Yang, Kaihong Huang, Shaojie Chen, Hai-gang Li, Linjuan Zeng, Jiajia Li, Yinting Chen, Guangsheng Ou, Jian-ning Chen, Guoda Lian
Publikováno v:
Gastric Cancer. 19:392-402
B-cell-specific Moloney murine leukemia virus integration site 1 (Bmi-1) and Raf kinase inhibitory protein (RKIP) are involved in cancer metastasis and chemotherapeutic resistance, respectively. In this study, we evaluated the association between Bmi